Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
05-Feb-2025 | 547 | 575.85 | 535.15 | 549.1 | 48,823 | 72,53,00,444.65 | 3,44,625 |
06-Feb-2025 | 551 | 644.8 | 546.05 | 607.35 | 1,88,635 | 5,19,89,84,471.15 | 15,47,494 |
07-Feb-2025 | 602 | 613.35 | 579.2 | 588.65 | 65,334 | 1,16,82,98,865.75 | 4,40,574 |
10-Feb-2025 | 582.55 | 587.85 | 532.8 | 551.2 | 61,906 | 1,03,04,92,417.1 | 5,44,011 |
11-Feb-2025 | 550 | 551.05 | 510 | 514.9 | 27,836 | 38,71,64,232.4 | 2,15,899 |
12-Feb-2025 | 515.95 | 540.8 | 502.85 | 530.1 | 41,186 | 68,81,66,531.95 | 3,51,617 |
13-Feb-2025 | 530.1 | 555.95 | 530.1 | 540.3 | 28,684 | 45,63,91,007.55 | 2,24,364 |
14-Feb-2025 | 543.95 | 552 | 498.9 | 515 | 32,349 | 52,15,21,641.4 | 2,44,489 |
17-Feb-2025 | 508.75 | 530.35 | 500.05 | 527.4 | 23,705 | 26,10,29,011.9 | 1,05,211 |
18-Feb-2025 | 526.5 | 534.85 | 501.1 | 512.75 | 25,220 | 26,87,34,809.85 | 1,54,749 |
19-Feb-2025 | 505 | 530.25 | 492.95 | 515.75 | 25,705 | 29,27,72,007.05 | 1,54,532 |
20-Feb-2025 | 515.75 | 536.75 | 513 | 533.8 | 15,907 | 21,50,65,502 | 1,25,042 |
21-Feb-2025 | 540 | 576 | 540 | 562.35 | 65,630 | 1,15,99,35,482.3 | 2,80,049 |
24-Feb-2025 | 542.05 | 566.25 | 535 | 556.3 | 23,191 | 34,82,13,892.15 | 1,03,359 |
25-Feb-2025 | 555 | 575.5 | 545.05 | 548.65 | 28,004 | 51,95,39,861.3 | 1,87,749 |
27-Feb-2025 | 562 | 585 | 545.75 | 567.6 | 45,559 | 88,50,66,923.3 | 2,81,487 |
28-Feb-2025 | 564.9 | 564.9 | 533.75 | 544.85 | 20,792 | 39,37,76,373.15 | 2,02,091 |
03-Mar-2025 | 550.95 | 555 | 516.5 | 530.5 | 23,866 | 34,96,14,807 | 1,72,933 |
04-Mar-2025 | 530.5 | 569 | 524.8 | 562.5 | 30,113 | 47,74,80,502.05 | 2,07,015 |
05-Mar-2025 | 564 | 600 | 563.95 | 596.75 | 49,152 | 98,06,06,935.85 | 4,20,034 |
06-Mar-2025 | 601.5 | 618 | 568.95 | 593.3 | 59,056 | 1,02,68,30,854.9 | 3,11,080 |
Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.
Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
